IKE Capital’s Amgen AMGN Stock Holding History

IKE Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.8M	Buy	+5,506	New	+$1.75M	1.57%	19

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

IKE Capital's AMGN Position: Q4 2025 in Review

IKE Capital opened a new position in Amgen (AMGN) in Q4 2025: 5,506 shares worth $1.8M. The stake represents 1.57% of the portfolio and ranks #19 among its holdings.

3,091 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

IKE Capital held 5,506 shares of Amgen worth $1.8M as of Q4 2025.
Amgen was a new IKE Capital position in Q4 2025.
Amgen made up 1.57% of IKE Capital's portfolio in Q4 2025, its #19 holding.
3,091 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on IKE Capital's 13F filing for Q4 2025, filed 19 Aug 2026.